AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
17min chapter
Your Brain On... Ozempic
Your Brain On
Exploring GLP-1 Agonists and Their Impact on Hunger Regulation, Weight Loss, and Cardiovascular Health
Delving into the science behind GLP-1 agonists like Ozempic and Victoza, the chapter discusses their role in reducing appetite, aiding weight loss, and improving cardiovascular outcomes for patients with type 2 diabetes and those with obesity. It also explores the potential of newer drugs like Wegovi and terzepatide in managing glycemic issues and weight loss. The conversation touches on the genetic factors influencing obesity, the behavioral side effects of medications altering food relationships, and the importance of monitoring patient tolerances to minimize side effects in diabetes management.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode